Results for heart failure translation from Lithuanian to English

my heart!“)
programme

heart lung transplant.2001, 20: 511) .
the three studies demonstrated similar survival rates.

ištrinti senus įrašussave failure cause unknown
delete old items

reduce the failure rate of vaccine candidates in phase iii clinical trials
reduce the failure rate of vaccine candidates in phase iii clinical trials.

adaptuota pagal “ prevention of coronary heart disease in clinical practice:
adapted from “ prevention of coronary heart disease in clinical practice:

new york heart association) funkcinės klasės širdies nepakankamumas, gydymo vildagliptinu patirties yra nedaug, todėl šiems
cardiac failure experience with vildagliptin therapy in patients with congestive heart failure of new york heart association (nyha) functional class i-ii is limited and therefore vildagliptin should be used

daytime processing may be extended and the closing time thereby delayed if an ssp failure has occurred during the day but has been resolved before 18.00 .
daytime processing may be extended and the closing time thereby delayed if an ssp failure has occurred during the day but has been resolved before 18.00 .

and allows participants to initiate backup lump sum and backup contingency payments in the event of a failure of the participant 's payment infrastructure .
and allows participants to initiate backup lump sum and backup contingency payments in the event of a failure of the participant 's payment infrastructure .

ancillary systems that require liquidity in the early morning need to have established means to cope with cases where the daytime processing cannot be started in time due to an ssp failure on the previous day .
ancillary systems that require liquidity in the early morning need to have established means to cope with cases where the daytime processing cannot be started in time due to an ssp failure on the previous day .

( d ) in the event that a failure affects an ancillary system , that ancillary system shall be responsible for resolving the failure .
( d ) in the event that a failure affects an ancillary system , that ancillary system shall be responsible for resolving the failure .

new york heart association) funkcinės klasės stazinis širdies nepakankamumas, gydymo vildagliptinu patirties yra nedaug, todėl šiems pacientams vildagliptino reikia skirti atsargiai.
cardiac failure experience with vildagliptin therapy in patients with congestive heart failure of new york heart association (nyha) functional class i-ii is limited and therefore vildagliptin should be used cautiously in these patients.

and ( c ) allows participants to initiate backup lump sum and backup contingency payments in the event of a failure of the participant 's payment infrastructure .
and ( c ) allows participants to initiate backup lump sum and backup contingency payments in the event of a failure of the participant 's payment infrastructure .

( b ) in the event of a failure of the ecb , some or all of its technical functions in relation to target2-ecb may be performed by other eurosystem cbs .
( b ) in the event of a failure of the ecb , some or all of its technical functions in relation to target2-ecb may be performed by other eurosystem cbs .

new york heart association classification) ne išemijos sukeltu širdies nepakankamumu sirgusiems pacientams amlodipinas didino plaučių edemos atvejų dažnį, bet pasunkėjusio širdies nepakankamumo atvejų dažnio, lyginant su placebo grupe, reikšmingai nedidino.
in a long-term, placebo-controlled study (praise-2) of amlodipine in patients with nyha (new york heart association classification) iii and iv heart failure of non-ischaemic aetiology, amlodipine was associated with increased reports of pulmonary oedema despite no significant difference in the incidence of worsening heart failure as compared to placebo.

14 (akf) inhibitoriais buvo susijs su oligurija ir (arba) progresuojancia azotemija, retais atvejais -su miniu inkst nepakankamumu ir (ar) mirtimi.panas poveik sukelia ir valsartanas.ilgalaikio placebu kontroliuojamo amlodipino tyrimo (praise-2) metu, iii ir iv stadijos pagal nyha (angl.new york heart association classification) ne isemijos sukeltu sirdies nepakankamumu sirgusiems pacientams amlodipinas didino plauci edemos atvej dazn, bet pasunkjusio sirdies nepakankamumo atvej daznio, lyginant su placebo grupe, reiksmingai nedidino.
similar outcomes have been reported with valsartan.in a long-term, placebo-controlled study (praise-2) of amlodipine in patients with nyha (new york heart association classification) iii and iv heart failure of non-ischaemic aetiology, amlodipine was associated with increased reports of pulmonary oedema despite no significant difference in the incidence of worsening heart failure as compared to placebo.